Skip to main content

Table 6 Comparison between the numbers of patients classified as responders/non-responders using each of the three evaluations versus pathology base Miller–Payne grading

From: Quantitative mathematical objective evaluation of contrast-enhanced spectral mammogram in the assessment of response to neoadjuvant chemotherapy and prediction of residual disease in breast cancer

 

Pathologic Response

Responder

Non-responder

Count (n = 39)

%

Count (n = 3)

%

Quantitative objective evaluation

Responder (n = 40)

39

100%

1

33.3%

Non-responder (n = 2)

0

0%

2

66.7%

RECIST 1.1 Evaluation

Responder (n = 35)

34

87.2%

1

33.3%

Non-responder (n = 7)

5

12.8%

2

66.7%

Combined response evaluation

Responder (n = 39)

38

97.4%

1

33.3%

Non-responder (n = 3)

1

2.6%

2

66.7%